We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
-17.1%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
-$1.36B
Cap. Flow
-$72.7M
Cap. Flow %
-1.28%
Top 10 Hldgs %
17.58%
Holding
1,139
New
165
Increased
376
Reduced
380
Closed
175

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$58.3M
2
CELG
Celgene Corp
CELG
+$27.6M
3
BMY icon
Bristol-Myers Squibb
BMY
+$23.3M
4
TJX icon
TJX Companies
TJX
+$23.1M
5
SNPS icon
Synopsys
SNPS
+$19.9M

Sector Composition

Rank Sector Weight
1 Technology 19.85%
2 Financials 17.71%
3 Consumer Discretionary 12.6%
4 Healthcare 11.49%
5 Industrials 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFT
901
DELISTED
Weatherford International plc
WFT
$174K ﹤0.01%
311,400
+86,500
+38% +$113K
BMCH
902
DELISTED
BMC Stock Holdings, Inc
BMCH
$170K ﹤0.01%
10,961
-38,867
-78% -$647K
LEE icon
903
Lee Enterprises
LEE
$166M
$166K ﹤0.01%
+7,891
New +$195K
NATR icon
904
Nature's Sunshine
NATR
$359M
$166K ﹤0.01%
20,398
+1,898
+10% +$16.4K
CSS
905
DELISTED
CSS Industries, Inc.
CSS
$165K ﹤0.01%
18,438
+1,400
+8% +$16.9K
OSG
906
DELISTED
Overseas Shipholding Group Inc.
OSG
$164K ﹤0.01%
99,039
+15,091
+18% +$38.3K
MACK
907
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$163K ﹤0.01%
53,643
UNT
908
DELISTED
UNIT Corporation
UNT
$160K ﹤0.01%
+11,200
New +$242K
MGI
909
DELISTED
MoneyGram International, Inc. New
MGI
$159K ﹤0.01%
79,700
+12,600
+19% +$40.5K
VSI
910
DELISTED
Vitamin Shoppe Inc.
VSI
$159K ﹤0.01%
33,635
+1,086
+3% +$8.15K
MRSN
911
DELISTED
Mersana Therapeutics
MRSN
$158K ﹤0.01%
+1,547
New +$245K
AGTC
912
DELISTED
Applied Genetic Technologies Corporation
AGTC
$158K ﹤0.01%
63,359
-14,000
-18% -$82K
SYNC
913
DELISTED
Synacor, Inc.
SYNC
$158K ﹤0.01%
106,882
SHBI icon
914
Shore Bancshares
SHBI
$790M
$155K ﹤0.01%
10,686
-200
-2% -$3.21K
AR icon
915
Antero Resources
AR
$10.9B
$154K ﹤0.01%
16,400
-166,147
-91% -$2.46M
CSLT
916
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$153K ﹤0.01%
70,610
+14,900
+27% +$37K
INFI
917
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$152K ﹤0.01%
129,127
+18,773
+17% +$33.8K
RNWK
918
DELISTED
RealNetworks Inc
RNWK
$151K ﹤0.01%
65,220
-3,500
-5% -$8.13K
HIND
919
Vyome Holdings
HIND
$14.5M
0
ISBC
920
DELISTED
Investors Bancorp, Inc.
ISBC
$150K ﹤0.01%
+14,400
New +$166K
SURF
921
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$149K ﹤0.01%
35,134
+22,900
+187% +$177K
ATXS
922
DELISTED
Astria Therapeutics
ATXS
$147K ﹤0.01%
+5,624
New +$213K
EGAN icon
923
eGain
EGAN
$176M
$146K ﹤0.01%
+22,162
New +$161K
ALSK
924
DELISTED
Alaska Communications Systems
ALSK
$145K ﹤0.01%
101,041
+22,484
+29% +$34.2K
PRDO icon
925
Perdoceo Education
PRDO
$1.9B
$143K ﹤0.01%
12,500
-18,500
-60% -$246K

Similar funds

Jacobs Levy Equity Management's Q4 2018 Portfolio in Review

As of Q4 2018, Jacobs Levy Equity Management held 1,139 positions worth $5.69B, down 19% from $7.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Jacobs Levy Equity Management's Q4 2018 filing shows 165 new, 376 increased, 380 reduced and 175 closed positions. Its largest new stake was Starbucks: 930,980 shares worth $60M. The largest sale was Dell, an estimated $45.2M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q4 2018 buy was Starbucks: 930,980 shares worth $60M.
  • Jacobs Levy Equity Management added most to Celgene Corp in Q4 2018, an estimated $27.6M increase.
  • Jacobs Levy Equity Management's biggest Q4 2018 reduction was Accenture, cutting an estimated $24M.
  • Jacobs Levy Equity Management fully exited Dell in Q4 2018, selling an estimated $45.2M.
  • Jacobs Levy Equity Management's ten largest holdings make up 18% of its $5.69B portfolio in Q4 2018.
  • Jacobs Levy Equity Management opened 165 new positions and closed 175 in Q4 2018.
  • Jacobs Levy Equity Management's portfolio value fell 19% quarter-over-quarter to $5.69B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2018, filed 14 Feb 2019.